Table 2 Characteristics of patients testing positive for anti-SARS-CoV-2 Spike protein IgG antibodies
Antibodies titre | BAU/mL |
|---|---|
- Mean ± SD | 482.3 ± 387.1 |
- Median | 387.4 |
- Interquartile range | 147.3–650.6 |
- Max | 1331.2 |
- Min | 87.9 |
Department | |
- Day Hospital | 8 (50) |
- Pediatric Surgery | 4 (25) |
- Blood Drawing Center | 2 (12.5) |
- Pediatrics | 1 (6.25) |
- Gastroenterology | 1 (6.25) |
- Emergency department | 0 |
Age | |
- Mean ± SD | 10.3 ± 4.1 |
- ≤ 5 | 3 (18.7) |
- 6–11 | 6 (37.6) |
- 12–17 | 7 (43.7) |
Sex | |
- M | 7 (43.7) |
- F | 9 (56.3) |
Citizenship | |
- Italy | 15 (93.7) |
- Albania | 1 (6.4) |
Comorbidities | 12 (75) |
- Malformation/Syndrome/Cerebral Palsy | 4 (33.4) |
- Obesity | 3 (25) |
- Prematurity | 2 (16.7) |
- Respiratory | 1 (8.3) |
- Diabetes | 1 (8.3) |
- Cardiac | 0 |
- Other | 1 (8.3) |
Cohabitant healthcare worker | 3 (18.7) |
- OR, 95% CI, p value | 1.53, 0.4–5.86, 0.46 |
Having an infected cohabitant | 10 (62.5) |
- OR, 95% CI, p value | 23.83, 7.19–78.98, < 0.0001 |
- 1 month before | 6 (60) |
- 2 months before | 1 (10) |
- 3 months before | 3 (30) |
- More than 3 months before | 0 |
- Tested by nasopharyngeal swab | 10 (100) |
- Positive | 4 (40) |
Nasopharyngeal swab | |
- Tested | 15 (93.7) |
- Positive | 5 (30) |
○ 1 month before | 2 (40) |
○ 2 months before | 2 (40) |
○ 3 months before | 1 (20) |
○ More than 3 months before | 0 |